Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Dermatological conditions are complex and treatments often have mixed results.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Current treatments for alopecia show no significant long-term benefits.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.